About SpectraWAVE
SpectraWAVE is a company based in Waltham (United States) founded in 2012 by Gregg Stone, Guillermo Tearney, and James Muller was acquired by Philips in December 2025.. SpectraWAVE has raised $79.88 million across 3 funding rounds from investors including Nova Ventures Group, Philips and Johnson & Johnson Innovation – JJDC. The company has 36 employees as of December 31, 2021. SpectraWAVE offers products and services including HyperVue Imaging System and Starlight Imaging Catheter. SpectraWAVE operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, IBA, GEN inCode and SD Biosensor, among others.
- Headquarter Waltham, United States
- Employees 36 as on 31 Dec, 2021
- Founders Gregg Stone, Guillermo Tearney, James Muller
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spectrawave, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$79.88 M (USD)
in 3 rounds
-
Latest Funding Round
$50.29 M (USD), Series B
Sep 04, 2024
-
Investors
Nova Ventures Group
& 8 more
-
Employee Count
36
as on Dec 31, 2021
-
Acquired by
Philips
(Dec 05, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpectraWAVE
SpectraWAVE offers a comprehensive portfolio of products and services, including HyperVue Imaging System and Starlight Imaging Catheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers high-resolution intravascular imaging for coronary artery analysis.
Enables imaging in vessels for interventional procedures and plaque assessment.
Unlock access to complete
Funding Insights of SpectraWAVE
SpectraWAVE has successfully raised a total of $79.88M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50.29 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $50.3M
-
First Round
First Round
(24 May 2019)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series B - SpectraWAVE | Valuation | Johnson & Johnson Innovation – JJDC | |
| Feb, 2021 | Amount | Series A - SpectraWAVE | Valuation | Deerfield |
|
| May, 2019 | Amount | Series A - SpectraWAVE | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SpectraWAVE
SpectraWAVE has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Nova Ventures Group, Philips and Johnson & Johnson Innovation – JJDC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided to Texas-based startups.
|
Founded Year | Domain | Location | |
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SpectraWAVE
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SpectraWAVE
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spectrawave Comparisons
Competitors of SpectraWAVE
SpectraWAVE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, IBA, GEN inCode and SD Biosensor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Technology tools and systems for molecular scale are developed.
|
|
| domain | founded_year | HQ Location |
Imaging solutions for macro, micro, and nano structures are provided.
|
|
| domain | founded_year | HQ Location |
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
|
|
| domain | founded_year | HQ Location |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| domain | founded_year | HQ Location |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spectrawave
Frequently Asked Questions about SpectraWAVE
When was SpectraWAVE founded?
SpectraWAVE was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Where is SpectraWAVE located?
SpectraWAVE is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Who is the current CEO of SpectraWAVE?
Eman Namati is the current CEO of SpectraWAVE.
Is SpectraWAVE a funded company?
SpectraWAVE is a funded company, having raised a total of $79.88M across 3 funding rounds to date. The company's 1st funding round was a Series A of $16.4M, raised on May 24, 2019.
How many employees does SpectraWAVE have?
As of Dec 31, 2021, the latest employee count at SpectraWAVE is 36.
What does SpectraWAVE do?
SpectraWAVE was founded in 2012 and is headquartered in Waltham, United States. Optical diagnostic and therapeutic devices are developed for the diagnosis and treatment of cardiovascular disease within the medical devices sector. Photonic imaging technology is employed to enable precise cardiovascular assessments. Operations center on advancing non-invasive solutions for clinical applications in cardiology.
Who are the top competitors of SpectraWAVE?
SpectraWAVE's top competitors include Oxford Instruments, Leica Microsystems and IBA.
What products or services does SpectraWAVE offer?
SpectraWAVE offers HyperVue Imaging System and Starlight Imaging Catheter.
Who are SpectraWAVE's investors?
SpectraWAVE has 9 investors. Key investors include Nova Ventures Group, Philips, Johnson & Johnson Innovation – JJDC, S3 Ventures, and Lumira Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.